Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger

Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger

Source: 
Fierce Pharma
News Tags: 
snippet: 

Akorn once again tried and failed to salvage its $4.3 billion merger with Fresenius. Delaware's top court ruled that Fresenius had nixed the deal legally after data problems cropped up, and in the wake of the decision, Akorn's CEO made his exit.